These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 24177324)
1. Modulation of protein C activation by histones, platelet factor 4, and heparinoids: new insights into activated protein C formation. Kowalska MA; Zhao G; Zhai L; David G; Marcus S; Krishnaswamy S; Poncz M Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):120-6. PubMed ID: 24177324 [TBL] [Abstract][Full Text] [Related]
3. Effects of unfractionated heparin, low-molecular-weight heparin, and heparinoid on thromboelastographic assay of blood coagulation. Zmuda K; Neofotistos D; Ts'ao CH Am J Clin Pathol; 2000 May; 113(5):725-31. PubMed ID: 10800406 [TBL] [Abstract][Full Text] [Related]
4. Antibodies associated with heparin-induced thrombocytopenia (HIT) inhibit activated protein C generation: new insights into the prothrombotic nature of HIT. Kowalska MA; Krishnaswamy S; Rauova L; Zhai L; Hayes V; Amirikian K; Esko JD; Bougie DW; Aster RH; Cines DB; Poncz M Blood; 2011 Sep; 118(10):2882-8. PubMed ID: 21772054 [TBL] [Abstract][Full Text] [Related]
5. Platelet factor 4 inhibits thrombomodulin-dependent activation of thrombin-activatable fibrinolysis inhibitor (TAFI) by thrombin. Mosnier LO J Biol Chem; 2011 Jan; 286(1):502-10. PubMed ID: 21041299 [TBL] [Abstract][Full Text] [Related]
6. Anticoagulant synergism of heparin and activated protein C in vitro. Role of a novel anticoagulant mechanism of heparin, enhancement of inactivation of factor V by activated protein C. Petäjä J; Fernández JA; Gruber A; Griffin JH J Clin Invest; 1997 Jun; 99(11):2655-63. PubMed ID: 9169495 [TBL] [Abstract][Full Text] [Related]
7. Thrombomodulin alfa attenuates the procoagulant effect and cytotoxicity of extracellular histones through the promotion of protein C activation. Osada K; Minami T; Arioka T; Sakai T; Tawara S; Kawasaki K; Fareed J; Matsuzaki O Thromb Res; 2017 Dec; 160():51-57. PubMed ID: 29101790 [TBL] [Abstract][Full Text] [Related]
8. Platelet factor 4 enhances generation of activated protein C in vitro and in vivo. Slungaard A; Fernandez JA; Griffin JH; Key NS; Long JR; Piegors DJ; Lentz SR Blood; 2003 Jul; 102(1):146-51. PubMed ID: 12609838 [TBL] [Abstract][Full Text] [Related]
9. Platelet factor 4 impairs the anticoagulant activity of activated protein C. Preston RJ; Tran S; Johnson JA; Ní Áinle F; Harmon S; White B; Smith OP; Jenkins PV; Dahlbäck B; O'Donnell JS J Biol Chem; 2009 Feb; 284(9):5869-75. PubMed ID: 19129181 [TBL] [Abstract][Full Text] [Related]
10. Protamine sulfate down-regulates thrombin generation by inhibiting factor V activation. Ni Ainle F; Preston RJ; Jenkins PV; Nel HJ; Johnson JA; Smith OP; White B; Fallon PG; O'Donnell JS Blood; 2009 Aug; 114(8):1658-65. PubMed ID: 19531655 [TBL] [Abstract][Full Text] [Related]
11. Platelet factor 4 modulation of the thrombomodulin-protein C system. Slungaard A Crit Care Med; 2004 May; 32(5 Suppl):S331-5. PubMed ID: 15118540 [TBL] [Abstract][Full Text] [Related]
12. Covalent antithrombin-heparin effect on thrombin-thrombomodulin and activated protein C reaction with factor V/Va. Van Walderveen MC; Berry LR; Atkinson HM; Chan AK Thromb Haemost; 2010 May; 103(5):910-9. PubMed ID: 20216984 [TBL] [Abstract][Full Text] [Related]
14. Neutralisation of the anti-coagulant effects of heparin by histones in blood plasma and purified systems. Longstaff C; Hogwood J; Gray E; Komorowicz E; Varjú I; Varga Z; Kolev K Thromb Haemost; 2016 Mar; 115(3):591-9. PubMed ID: 26632486 [TBL] [Abstract][Full Text] [Related]
15. Additive effects of anticoagulants: recombinant human activated protein C and heparin or melagatran, in tissue factor-activated umbilical-cord plasma. Koestenberger M; Gallistl S; Muntean W; Leschnik B; Fritsch P; Cvirn G Thromb Haemost; 2005 Jul; 94(1):69-74. PubMed ID: 16113786 [TBL] [Abstract][Full Text] [Related]
16. Endogenous platelet factor 4 stimulates activated protein C generation in vivo and improves survival after thrombin or lipopolysaccharide challenge. Kowalska MA; Mahmud SA; Lambert MP; Poncz M; Slungaard A Blood; 2007 Sep; 110(6):1903-5. PubMed ID: 17540840 [TBL] [Abstract][Full Text] [Related]
17. Effect of heparin and heparinoids on platelet aggregation. Cepelák V; Roubal Z; Zemanová I; Opatrný K Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):750-60. PubMed ID: 6083950 [TBL] [Abstract][Full Text] [Related]
18. Dermatan sulfate and LMW heparin enhance the anticoagulant action of activated protein C. Fernández JA; Petäjä J; Griffin JH Thromb Haemost; 1999 Nov; 82(5):1462-8. PubMed ID: 10595639 [TBL] [Abstract][Full Text] [Related]
19. Heparinoids algal and their anticoagulant, hemorrhagic activities and platelet aggregation. de Azevedo TC; Bezerra ME; Santos Mda G; Souza LA; Marques CT; Benevides NM; Leite EL Biomed Pharmacother; 2009 Aug; 63(7):477-83. PubMed ID: 19006655 [TBL] [Abstract][Full Text] [Related]